SCOPUS 정보 검색 플랫폼

Clinical Infectious Diseases

Volumn 31, Issue 5, 2000, Pages 1209-1215

Susceptibility testing for mycobacteria

(1) Woods, G L a

a University of Texas Medical Branch School of Medicine (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; IMIPENEM; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TOBRAMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL GROWTH; DRUG SENSITIVITY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; SPECIES SPECIFICITY;

EID: 0034458275 PISSN: 10584838 EISSN: None Source Type: Journal
DOI: 10.1086/317441 Document Type: Article

Times cited : (135)

References (27)

1
- 0004012839
- Tentative standard M24-T Wayne, PA: National Committee for Clinical Laboratory Standards
- (1995) Antimycobacterial susceptibility testing for Mycobacterium tuberculosis

2
- 0004318230
- Tentative standard M24-T2 Wayne, PA: National Committee for Clinical Laboratory Standards National Committee for Clinical Laboratory Standards (in press)
- Susceptibility testing of mycobacteria, Nocardia, and other aerobic actinomycetes. 2d ed.

3
- 0345508902
- Antituberculosis chemotherapy and drug susceptibility testing
- Kent PT, Kubica GP. Public health mycobacteriology: A guide for the level III laboratory. Atlanta, GA: Centers for Disease Control and Prevention
- (1985) , pp. 159-184
- Kent, P.T.¹ Kubica, G.P.²

4
- 0027474621
- The resurgence of tuberculosis: Is your laboratory ready?
- (1993) J Clin Microbiol , vol.31 , pp. 767-770
- Tenover, F.C.¹ Crawford, J.T.² Huebner, R.E.³

5
- 0022340966
- Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods
- (1985) J Clin Microbiol , vol.22 , pp. 919-923
- Siddiqi, S.H.¹ Hawkins, J.E.² Laszlo, A.³

6
- 0028887921
- Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists' Mycobacteriology E survey: Results of a 1993 questionnaire
- (1995) J Clin Microbiol , vol.33 , pp. 407-412
- Woods, G.L.¹ Witebsky, F.G.²

7
- 0031690041
- Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs
- (1998) J Clin Microbiol , vol.36 , pp. 2940-2943
- Bergmann, J.S.¹ Woods, G.L.²

8
- 0033983156
- Evaluation of the BBL MGIT (mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs
- (2000) Arch Pathol Lab Med , vol.124 , pp. 82-86
- Bergmann, J.S.¹ Fish, G.² Woods, G.L.³

9
- 0030758758
- Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Thoracic Society Statement
- (1997) Am J Resp Crit Care Med , vol.156
- Wallace R.J., Jr.¹ Glassroth, J.² Griffith, D.E.³ Olivier, K.N.⁴

10
- 0030743379
- Microbiology and minimum inhibitory concentration testing for Mycobacterium avium complex prophylaxis
- (1997) Am J Med , vol.102 , pp. 2-10
- Inderlied, C.B.¹

11
- 0028063769
- Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: A randomized, double-blind, dose-ranging study in patients with AIDS
- AIDS Clinical Trials Group Protocol 157 Study Team
- (1994) Ann Intern Med , vol.121 , pp. 905-911
- Chaisson, R.E.¹ Benson, C.A.² Dube, M.P.³

12
- 0002308805
- Antimycobacterial agents and susceptibility tests
- Murray PR, Baron EJ, Pfaller MA, et al., eds. Washington, DC: ASM Press
- (1999) Manual of clinical microbiology. 7th ed. , pp. 1601-1623
- Inderlied, C.B.¹ Salfinger, M.²

13
- 0030021732
- Treatment of Mycobacterium avium complex infection: Do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
- (1996) J Infect Dis , vol.173 , pp. 677-683
- Sisson, J.P.¹ Yao, Y.² Kemper, C.A.³

14
- 0027301337
- Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates
- (1993) J Clin Microbiol , vol.31 , pp. 2332-2338
- Siddiqi, S.H.¹ Heifets, L.B.² Cynamon, M.H.³

15
- 0026657212
- Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system
- (1992) Antimicrob Agents Chemother , vol.36 , pp. 1987-1990
- Brown, B.A.¹ Wallace R.J., Jr.² Onyi, G.O.³

16
- 0026606393
- Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium
- (1992) Am Rev Respir Dis , vol.145 , pp. 856-858
- Heifers, L.B.¹ Lindholm-Levy, P.J.² Comstock, R.D.³

17
- 0029795936
- Susceptibility testing of Mycobacterium avium complex isolates
- (1996) Antimicrob Agents Chemother , vol.40 , pp. 1759-1767
- Heifers, L.¹

18
- 0028800955
- Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease
- (1995) Antimicrob Agents Chemother , vol.39 , pp. 2625-2630
- Nash, K.A.¹ Inderlied, C.B.²

19
- 0030003258
- Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: Observation of multiple 23S rDNA mutations in a clonal population
- (1996) J Infect Dis , vol.174 , pp. 354-360
- Meier, A.¹ Heifets, L.² Wallace R.J., Jr.³

20
- 0028204381
- Rifampin-resistant Mycobacterium kansasii
- (1994) Clin Infect Dis , vol.18 , pp. 736-743
- Wallace R.J., Jr.¹ Dunbar, D.² Brown, B.A.³

21
- 0021926820
- Use of the Bactec system for drug susceptibility testing of Mycobacterium tuberculosis. M. kansasii, and M. avium complex
- (1985) Diagn Microbiol Infect Dis , vol.3 , pp. 33-40
- Steadham, J.E.¹ Stall, S.K.² Simmank, J.L.³

22
- 0023023318
- Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth
- (1986) J Clin Microbiol , vol.24 , pp. 976-981
- Wallace R.J., Jr.¹ Nash, D.R.² Stelle, L.C.³

23
- 0020318936
- Rapidly growing mycobacteria: Testing of susceptibility to 34 antimicrobial agents by broth microdilution
- (1982) Antimicrob Agents Chemother , vol.22 , pp. 186-192
- Swenson, J.M.¹ Thornsberry, C.² Silcox, V.A.³

24
- 0022355533
- Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae
- (1985) Antimicrob Agents Chemother , vol.28 , pp. 807-811
- Swenson, J.M.¹ Wallace R.J., Jr.² Silcox, V.A.³

25
- 0025753436
- Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobocterium chelonoe to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid
- (1991) Antimicrob Agents Chemother , vol.35 , pp. 773-775
- Wallace R.J., Jr.¹ Brown, B.A.² Onyi, G.O.³

26
- 0032930591
- Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium obscessus, Mycobocterium chelonae, and Mycobacterium fortuitum
- (1999) J Clin Microbiol , vol.37 , pp. 1676-1682
- Woods, G.L.¹ Bergmann, J.S.² Witebsky, F.G.³

27
- 0033950611
- Multisite reproducibility of Etest for susceptibility testing of Mycobocterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum
- (2000) J Clin Microbiol , vol.38 , pp. 656-661
- Woods, G.L.¹ Bergmann, J.S.² Witebsky, F.G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.